The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

Abstract

Deciphering Multiple Myeloma evolution in the whole bone marrow is key to inform curative strategies. Here, we perform spatial-longitudinal whole-exome sequencing, including 140 samples collected from 24 Multiple Myeloma patients during up to 14 years. Applying imaging-guided sampling we observe three evolutionary patterns, including relapse driven by a single-cell expansion, competing/co-existing sub-clones, and unique sub-clones at distinct locations. While we do not find the unique relapse sub-clone in the baseline focal lesion(s), we show a close phylogenetic relationship between baseline focal lesions and relapse disease, highlighting focal lesions as hotspots of tumor evolution. In patients with ≥3 focal lesions on positron-emission-tomography at diagnosis, relapse is driven by multiple distinct sub-clones, whereas in other patients, a single-cell expansion is typically seen (p < 0.01). Notably, we observe resistant sub-clones that can be hidden over years, suggesting that a prerequisite for curative therapies would be to overcome not only tumor heterogeneity but also dormancy.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Rasche, L., Schinke, C., Maura, F., Bauer, M. A., Ashby, C., Deshpande, S., Poos, A. M., Zangari, M., Thanendrarajan, S., Davies, F. E., Walker, B. A., Barlogie, B., Landgren, O., Morgan, G. J., van Rhee, F., & Weinhold, N. (2022). The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states. Nature Communications, 13(1), 4517. https://doi.org/10.1038/s41467-022-32145-y
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Nature Communications
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}